Evidence map›Paper›PMID 28208263›Full record

ArticleAnalytical chemistry2017

Visualization, Quantification, and Alignment of Spectral Drift in Population Scale Untargeted Metabolomics Data.

Jeramie D Watrous, Mir Henglin, Brian Claggett, Kim A Lehmann, Martin G Larson, Susan Cheng, Mohit Jain

Abstract read
In one paragraph

Article in Analytical chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. [Alignment method for metabolite chromatographic peaks using anSe pu = Chinese journal of chromatography · 2024
    Article
  6. Article
  7. Article
  8. An epidemiological introduction to human metabolomic investigations.Trends in endocrinology and metabolism: TEM · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Mass Spectrometry-based Metabolomics in Translational Research.Advances in experimental medicine and biology · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jeramie D WatrousDepartments of Medicine and Pharmacology, University of California San Diego , La Jolla, California 92093, United States.ORCID 0000-0001-9124-6783
Mir HenglinCardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts 02115, United States.
Brian ClaggettCardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts 02115, United States.
Kim A LehmannDepartments of Medicine and Pharmacology, University of California San Diego , La Jolla, California 92093, United States.
Martin G LarsonFramingham Heart Study , Framingham, Massachusetts 01702, United States.
Susan ChengCardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts 02115, United States.
Mohit JainDepartments of Medicine and Pharmacology, University of California San Diego , La Jolla, California 92093, United States.

Funding

Mapping the Plasma Exposome and its Association with Human Cardiovascular DiseaseR01ES027595 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JAIN, MOHIT · 2017 to 2021
$3.3M
Inflammatory Mediators, Cardiovascular Health, and Longevity in WomenR01HL134168 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI CHENG, SUSAN · 2016 to 2019
$1.6M
RapidFire mass spectrometry systemS10OD020025 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JAIN, MOHIT · 2015 to 2015
$600k
Reactive electrophiles in human aging and longevityR03AG053287 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JAIN, MOHIT · 2016 to 2017
$233k
Doris Duke Charitable Foundation 2015092NHLBI NIH HHS R01 HL134168NIA NIH HHS R03 AG053287NIEHS NIH HHS R01 ES027595NIH HHS S10 OD020025
6 · The paper itself

Abstract

Untargeted liquid-chromatography-mass spectrometry (LC-MS)-based metabolomics analysis of human biospecimens has become among the most promising strategies for probing the underpinnings of human health and disease. Analysis of spectral data across population scale cohorts, however, is precluded by day-to-day nonlinear signal drifts in LC retention time or batch effects that complicate comparison of thousands of untargeted peaks. To date, there exists no efficient means of visualization and quantitative assessment of signal drift, correction of drift when present, and automated filtering of unstable spectral features, particularly across thousands of data files in population scale experiments. Herein, we report the development of a set of R-based scripts that allow for pre- and postprocessing of raw LC-MS data. These methods can be integrated with existing data analysis workflows by providing initial preprocessing bulk nonlinear retention time correction at the raw data level. Further, this approach provides postprocessing visualization and quantification of peak alignment accuracy, as well as peak-reliability-based parsing of processed data through hierarchical clustering of signal profiles. In a metabolomics data set derived from ∼3000 human plasma samples, we find that application of our alignment tools resulted in substantial improvement in peak alignment accuracy, automated data filtering, and ultimately statistical power for detection of metabolite correlates of clinical measures. These tools will enable metabolomics studies of population scale cohorts.

Indexed as

Chromatography, High Pressure LiquidCluster AnalysisHumansMetabolomicsPlasmaTandem Mass Spectrometry

Identifiers

PMID28208263
PMCPMC5455767

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.